| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 10 |
| 1 | ESOMEPRAZOLE MAGNESIUM | 9 |
| 2 | CYCLOSPORINE | 8 |
| 3 | TACROLIMUS | 8 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 8 |
| 5 | TACROLIMUS OINTMENT 0.1% | 8 |
| 6 | MAGNESIUM OXIDE | 7 |
| 7 | DARUNAVIR | 6 |
| 8 | FUROSEMIDE | 6 |
| 9 | RITONAVIR | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 1 | MARAVIROC | 4 | 0.0017 |
| 2 | ADEFOVIR DIPIVOXIL | 2 | 0.0016 |
| 3 | PRALATREXATE | 1 | 0.0015 |
| 4 | RALTEGRAVIR | 5 | 0.0010 |
| 5 | PASIREOTIDE | 2 | 0.0009 |
| 6 | ETRAVIRINE | 3 | 0.0007 |
| 7 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 8 | LANTHANUM CARBONATE | 3 | 0.0006 |
| 9 | PEGCETACOPLAN | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 4 | 0.0017 |
| 1 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 3 | 0.0001 |
| 4 | Protease Inhibitor [EPC] | 6 | 0.0001 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Bile Acid [EPC] | 3 | 0.0001 |
| 7 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |